ZEVEX International Sponsors Cancer and Nutrition Symposium, Expands Market Opportunity
15 7월 2004 - 11:15PM
PR Newswire (US)
ZEVEX International Sponsors Cancer and Nutrition Symposium,
Expands Market Opportunity SALT LAKE CITY, July 15
/PRNewswire-FirstCall/ -- ZEVEX International, Inc., (NASDAQ:ZVXI)
manufacturer and marketer of the EnteraLite(R) ambulatory enteral
feeding pump, announced it was one of the major sponsors of the
11th Symposium on Nutrition and Cancer held on July 8-9, 2004,
hosted by the University of Texas in Houston and the Centers for
Disease Control in Atlanta. The symposium was held at MD Anderson
Cancer Center at the University of Texas, which U.S. News and World
Report named the leading cancer center in the U.S. for the third
year in a row in its annual ranking. Clinicians who specialize in
nutrition and oncology from around the globe attended the
symposium. David McNally, Chairman and CEO of ZEVEX, said, "Enteral
nutrition delivery for cancer patients represents a new market
opportunity for ZEVEX. The initial response by clinicians at the
symposium to the EnteraLite was very encouraging, and we have
already begun providing EnteraLite pumps to home care cancer
patients who can continue their radiation and chemotherapy
treatments as outpatients. The EnteraLite brings a great
improvements to these patients' quality of life through its
portability and ease of use." At present, pediatric enteral
nutrition consumers are the primary users of ZEVEX' EnteraLite.
According to Frost & Sullivan and internal company estimates,
the U.S. market for enteral nutrition delivery for feeding pumps
and associated administration sets is at least $250 million
annually. Current procedures for feeding cancer patients may
require them to interrupt their radiation or chemotherapy
treatments and report for a feeding regimen using a stationary
pump. Because the ZEVEX pump is portable, patients can receive
treatment, return to their normal lives and even go to work while
receiving better nutrition delivery. Many patients who use the
EnteraLite have reported their ability to maintain or gain weight.
ABOUT ZEVEX ZEVEX International, Inc., (http://www.zevex.com/),
founded in 1986, is a diversified medical device company committed
to creating products that transform life with patented and
proprietary medical device technologies -- from sensors and
surgical tools to medical electronic systems. This article is
current as of the date of original publication and is provided for
historical informational purposes only. ZEVEX makes no
representations that the information in this article is current as
of the date the article is accessed and takes no responsibility for
updating the information contained in its articles. DATASOURCE:
ZEVEX International, Inc. CONTACT: Nancy E. Schultz, Director,
Corporate Communications/Investor Relations, ZEVEX International,
Inc., +1-801-264-1001 ext. 203, fax +1-801-264-1051, Web site:
http://www.zevex.com/
Copyright
Zevex (NASDAQ:ZVXI)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Zevex (NASDAQ:ZVXI)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
Zevex International (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Zevex International (MM) News Articles